Ayala Pharmaceuticals Inc (ADXS)

[jckrdu]

"Although I admit that I still see no reason to suspend new enrollments while the FDA reviews this information."
_________________________

Yeah, I hear you. KB didn't elaborate much on the specifics of the FDA's questions. IMO, the questions appear significant enough (from the FDA's perspective) that they don't want new patients enrolled until they get the information they asked for.

Hopefully ADXS replies quickly, and the FDA is fully satisfied in a short amount of time, and this is a non-issue.